Literature DB >> 10713690

Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation.

C X Deng1, F Scott.   

Abstract

Germline mutations in the tumor suppressor BRCA1 predispose women to breast and ovarian cancers. Current evidence demonstrates that mutations in BRCA1 do not directly result in tumor formation, but instead cause genetic instability, subjecting cells to high risks of malignant transformation. In an animal model in which Brca1 is mutated specifically in mammary epithelium, tumorigenesis occurs in mutant glands at low frequency after a long latency. Notably, introduction of a p53-null allele significantly enhanced mammary gland tumor formation in Brca1 conditional mutant mice. These results are consistent with a model that Brca1 is a caretaker gene, whose absence causes genetic instability and triggers further alterations, including inactivation of tumor suppressor genes and/or activation of oncogenes, leading to tumor formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713690     DOI: 10.1038/sj.onc.1203269

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  49 in total

Review 1.  Cell cycle checkpoints and their inactivation in human cancer.

Authors:  M Molinari
Journal:  Cell Prolif       Date:  2000-10       Impact factor: 6.831

2.  BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets.

Authors:  Timothy K MacLachlan; Rishu Takimoto; Wafik S El-Deiry
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

3.  Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains.

Authors:  Donna L Mallery; Cassandra J Vandenberg; Kevin Hiom
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

4.  Direct DNA binding by Brca1.

Authors:  T T Paull; D Cortez; B Bowers; S J Elledge; M Gellert
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

5.  Tumorigenesis in mice carrying a truncating Brca1 mutation.

Authors:  T Ludwig; P Fisher; S Ganesan; A Efstratiadis
Journal:  Genes Dev       Date:  2001-05-15       Impact factor: 11.361

6.  Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform.

Authors:  Liu Cao; Wenmei Li; Sangsoo Kim; Steven G Brodie; Chu-Xia Deng
Journal:  Genes Dev       Date:  2003-01-15       Impact factor: 11.361

7.  The PARP inhibitors, veliparib and olaparib, are effective chemopreventive agents for delaying mammary tumor development in BRCA1-deficient mice.

Authors:  Ciric To; Eun-Hee Kim; Darlene B Royce; Charlotte R Williams; Ryan M Collins; Renee Risingsong; Michael B Sporn; Karen T Liby
Journal:  Cancer Prev Res (Phila)       Date:  2014-05-09

Review 8.  Of mice and Myc: c-Myc and mammary tumorigenesis.

Authors:  M Hunter Jamerson; Michael D Johnson; Robert B Dickson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

9.  Differences in 53BP1 and BRCA1 regulation between cycling and non-cycling cells.

Authors:  Monica Croke; Martin A Neumann; David A Grotsky; Ray Kreienkamp; Sree C Yaddanapudi; Susana Gonzalo
Journal:  Cell Cycle       Date:  2013-10-02       Impact factor: 4.534

10.  Identification of Flightless-I as a substrate of the cytokine-independent survival kinase CISK.

Authors:  Jun Xu; Lan Liao; Jun Qin; Jianming Xu; Dan Liu; Zhou Songyang
Journal:  J Biol Chem       Date:  2009-03-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.